PatientsVille.com Logo

PatientsVille

Antihemophilic Side Effects

Report Antihemophilic Side Effects

If you experienced any harmful or unwanted effects of Antihemophilic, please share your experience. This could help to raise awareness about Antihemophilic side effects, identify uknown risks and inform health professionals and patients taking Antihemophilic.

Examples: headache, dizziness


Antihemophilic Side Effects reported to FDA

The following Antihemophilic reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
The FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Antihemophilic on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has identified a causal relationship between the drug and the listed risk.

Page 1 of 3 

Anti Factor Viii Antibody Positive, Haematoma
on Jul 27, 2011 Male from MEXICO , child 10 years of age, weighting 70.55 lb, was diagnosed with and was treated with Antihemophilic Factor (recombinant), Sucrose Formulated Fs. Directly after, patient experienced the unwanted or unexpected Antihemophilic side effects: anti factor viii antibody positive, haematoma. Antihemophilic Factor (recombinant), Sucrose Formulated Fs dosage: N/A.

Factor Viii Inhibition
Patient was taking Antihemophilic Factor (human). Patient felt the following Antihemophilic side effects: factor viii inhibition on Jul 13, 2011 from CHINA Additional patient health information: Male , 32 years of age, weighting 169.8 lb, was diagnosed with and. Antihemophilic Factor (human) dosage: 3549.0iu Given For Initial Recovery.

Factor Viii Inhibition
Adverse event was reported on Jul 15, 2011 by a Male taking Antihemophilic Factor (human) (Dosage: 3000iu Given For Initial Recovery) was diagnosed with and. Location: CHINA , 29 years of age, weighting 143.3 lb, After Antihemophilic was administered, patient encountered several Antihemophilic side effects: factor viii inhibition.

Factor Viii Inhibition
on Jul 15, 2011 Male from CHINA , 20 years of age, weighting 88.18 lb, was treated with Antihemophilic Factor (human). Directly after, patient experienced the unwanted or unexpected Antihemophilic side effects: factor viii inhibition. Antihemophilic Factor (human) dosage: 1000.0iu Given On Demand.


No Adverse Event
on Jun 29, 2011 Male from UNITED STATES , 29 years of age, weighting 155.2 lb, was treated with Antihemophilic Factor Nos. Patient felt the following Antihemophilic side effects: no adverse event. Antihemophilic Factor Nos dosage: 1775 U, Tiw.

Hepatitis C, Hepatic Cirrhosis, Hepatic Neoplasm Malignant
Patient was taking Antihemophilic Factor (human). After Antihemophilic was administered, patient encountered several Antihemophilic side effects: hepatitis c, hepatic cirrhosis, hepatic neoplasm malignant on Jun 29, 2011 from UNITED STATES Additional patient health information: Male , weighting 83.78 lb, was diagnosed with and. Antihemophilic Factor (human) dosage: N/A.
Multiple concurrent drugs taken:

Headache, Nausea, Hypersensitivity
Adverse event was reported on Mar 21, 2011 by a Male taking Antihemophilic Factor (recombinant), Sucrose Formulated Fs (Dosage: N/A) was diagnosed with and. Location: UNITED STATES , 50 years of age, Directly after, patient experienced the unwanted or unexpected Antihemophilic side effects: headache, nausea, hypersensitivity.

Depression, Nervousness, Multi-organ Failure, Renal Disorder, Emotional Distress, Anxiety, Renal Injury, Fear
on Mar 09, 2011 Male from UNITED STATES , weighting 282.2 lb, was treated with Antihemophilic Factor (human). Patient felt the following Antihemophilic side effects: depression, nervousness, multi-organ failure, renal disorder, emotional distress, anxiety, renal injury, fear. Antihemophilic Factor (human) dosage: 12,000 Units.
Multiple prescriptions taken:
  • Bentyl (10 Mg, Tid)
  • Insulin
  • Cordarone (Unk)
  • Platelets (36 Units)
  • Plasma (12 Units)
  • Cryoprecipitates (30 Units)
  • Lipitor (20 Mg, Qd)
  • Solu-medrol (500 Mg, Unk)


Factor Viii Inhibition, Haemorrhage
on Jan 12, 2011 Patient from NETHERLANDS , 18 years of age, was diagnosed with and was treated with Antihemophilic Factor (human). After Antihemophilic was administered, patient encountered several Antihemophilic side effects: factor viii inhibition, haemorrhage. Antihemophilic Factor (human) dosage: N/A.

Haemorrhage, Factor Viii Inhibition
Patient was taking Antihemophilic Factor (human). Directly after, patient experienced the unwanted or unexpected Antihemophilic side effects: haemorrhage, factor viii inhibition on Jan 12, 2011 from NETHERLANDS Additional patient health information: Patient , 18 years of age, was diagnosed with and. Antihemophilic Factor (human) dosage: N/A.

Factor Viii Inhibition, Haemorrhage
Adverse event was reported on Jan 12, 2011 by a Patient taking Antihemophilic Factor (human) (Dosage: N/A) was diagnosed with and. Location: NETHERLANDS , 63 years of age, Patient felt the following Antihemophilic side effects: factor viii inhibition, haemorrhage.

Rash
on Dec 07, 2010 Male from UNITED STATES , 54 years of age, weighting 173.5 lb, was diagnosed with and was treated with Antihemophilic Factor (human). After Antihemophilic was administered, patient encountered several Antihemophilic side effects: rash. Antihemophilic Factor (human) dosage: 2000 Units Once Iv.

Factor Viii Inhibition, Impaired Healing
on Oct 07, 2010 Male from GERMANY , 60 years of age, was diagnosed with and was treated with Antihemophilic Factor (human). Directly after, patient experienced the unwanted or unexpected Antihemophilic side effects: factor viii inhibition, impaired healing. Antihemophilic Factor (human) dosage: N/A.
Associated medications used:

Factor Viii Inhibition
Patient was taking Antihemophilic Factor (human). Patient felt the following Antihemophilic side effects: factor viii inhibition on Aug 03, 2009 from UNITED STATES Additional patient health information: Male , child 4 years of age, was diagnosed with and. Antihemophilic Factor (human) dosage: ;as Needed;.


Adverse event was reported on Jun 10, 2010 by a Male taking Antihemophilic Factor (human) (Dosage: N/A) . Location: UNITED STATES , 37 years of age, .

Factor Viii Inhibition, Myocardial Infarction, Thrombosis
on Apr 05, 2010 Patient from UNITED STATES , 15 years of age, was treated with Antihemophilic Factor (human). Directly after, patient experienced the unwanted or unexpected Antihemophilic side effects: factor viii inhibition, myocardial infarction, thrombosis. Antihemophilic Factor (human) dosage: N/A.

Factor Viii Inhibition
on Oct 22, 2007 Male from UNITED STATES , 38 years of age, was diagnosed with and was treated with Antihemophilic Factor (human). Patient felt the following Antihemophilic side effects: factor viii inhibition. Antihemophilic Factor (human) dosage: N/A.
Multiple prescriptions taken:

Factor Viii Inhibition
Patient was taking Antihemophilic Factor (human). After Antihemophilic was administered, patient encountered several Antihemophilic side effects: factor viii inhibition on Oct 22, 2007 from UNITED STATES Additional patient health information: Patient , 52 years of age, was diagnosed with and. Antihemophilic Factor (human) dosage: N/A.

Factor Viii Inhibition
Adverse event was reported on Oct 22, 2007 by a Patient taking Antihemophilic Factor (human) (Dosage: 12 Treatments; Every Mo) was diagnosed with and. Location: UNITED STATES , 17 years of age, Directly after, patient experienced the unwanted or unexpected Antihemophilic side effects: factor viii inhibition.

Factor Viii Inhibition
on Oct 24, 2007 Patient from UNITED STATES , 13 years of age, was diagnosed with and was treated with Antihemophilic Factor (human). Patient felt the following Antihemophilic side effects: factor viii inhibition. Antihemophilic Factor (human) dosage: N/A.

Platelet Count Decreased, White Blood Cell Count Decreased
on Nov 05, 2008 Female from AUSTRIA , 55 years of age, weighting 163.1 lb, was diagnosed with and was treated with Antihemophilic Factor Nos. After Antihemophilic was administered, patient encountered several Antihemophilic side effects: platelet count decreased, white blood cell count decreased. Antihemophilic Factor Nos dosage: Iv. Patient was hospitalized.

Platelet Count Decreased, White Blood Cell Count Decreased
Patient was taking Antihemophilic Factor Nos. Directly after, patient experienced the unwanted or unexpected Antihemophilic side effects: platelet count decreased, white blood cell count decreased on Oct 26, 2008 from AUSTRIA Additional patient health information: Female , 55 years of age, weighting 163.1 lb, was diagnosed with and. Antihemophilic Factor Nos dosage: Iv. Patient was hospitalized.

Anaphylactic Reaction, Pulmonary Oedema, Shock
Adverse event was reported on Aug 14, 2008 by a Female taking Antihemophilic Factor Nos (Dosage: Once Iv) was diagnosed with and. Location: GERMANY , 68 years of age, weighting 143.3 lb, Patient felt the following Antihemophilic side effects: anaphylactic reaction, pulmonary oedema, shock. Patient was hospitalized.

Hypotension, Pulmonary Oedema, Shock, Somnolence
on Aug 07, 2008 Female from GERMANY , 68 years of age, weighting 143.3 lb, was diagnosed with and was treated with Antihemophilic Factor Nos. After Antihemophilic was administered, patient encountered several Antihemophilic side effects: hypotension, pulmonary oedema, shock, somnolence. Antihemophilic Factor Nos dosage: 1000 U Once; Iv; 500 U Once Iv. Patient was hospitalized.

Factor Viii Inhibition, Haemorrhage
on Apr 27, 2005 Male from , 49 years of age, weighting 180.8 lb, was diagnosed with and was treated with Antihemophilic Factor (human). Directly after, patient experienced the unwanted or unexpected Antihemophilic side effects: factor viii inhibition, haemorrhage. Antihemophilic Factor (human) dosage: N/A. Patient was hospitalized.

Page 1 of 3 

Record and Track Your Side Effects

It is very important to keep track of all side effects and discuss them with your doctor. If you think you may have a medical emergency, call your doctor or 911 immediately.

Track Your Side Effects - It's Easy and Free. >> Start Today

Already a User? Log In

Most drugs have a large list of nonsevere or mild adverse effects which do not rule out continued usage. These effects depend on individual sensitivity, and can include nausea, dizziness, diarrhea, malaise, vomiting, headache, dermatitis, dry mouth, etc. Check commonly reported side effects . These can be considered a form of pseudo-allergic reaction, as not all users experience these effects; many users experience none at all.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

Tips for Taking Medicines Properly

Before Taking Antihemophilic

Find Out How to Take Antihemophilic

Discuss Antihemophilic Side Effects

Did You Have a Antihemophilic Side Effect?

Yes, Severe
Yes, Moderate
Yes, Minor
No

How Effective is Antihemophilic for You?

Exceeded Expectations
Effective
Somewhat Effective
Not Effective


JustAnswer.com

Safety Alerts, Active Ingredients, Usage Information

More About Antihemophilic

Side Effects reported to FDA: 51

Antihemophilic safety alerts: 2000

Reported deaths: 5

Reported hospitalizations: 4

Helixate (antihemophilic factor [recombinant])

Voluntary withdrawal of Helixate lot number 670H071E. This lot of Helixate was tested for Factor VIII potency using a reagent known as FVIII-deficient plasma. During a routine quality assurance investigation of the testing procedure, Bayer learned that Lot 670H071 may not retain its labeled potency if held at room temperature (25° C) for 3 months. The product will remain stable if stored at 2-8° C. Further investigation has confirmed that the cause is not related to a stability issue with the product but is attributed to the reagent used during the initial testing. As of this date there have been no adverse events reported in association with this lot of Helixate.

[August 1, 2000 - Letter - Aventis Behring]

Latest Antihemophilic clinical trials

Related health facts